Steward Partners Investment Advisory, LLC Harrow Health, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $11 Billion
- Q4 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 83,940 shares of HROW stock, worth $2.6 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
83,940
Previous 89,220
5.92%
Holding current value
$2.6 Million
Previous $4.01 Million
29.79%
% of portfolio
0.03%
Previous 0.04%
Shares
8 transactions
Others Institutions Holding HROW
# of Institutions
175Shares Held
21.2MCall Options Held
844KPut Options Held
698K-
Opaleye Management Inc. Boston, MA3.99MShares$124 Million32.75% of portfolio
-
Private Capital Management, LLC Naples, FL2.16MShares$67.1 Million11.41% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$66.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$57.9 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$22.7 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $839M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...